KERACNYL PP+

Anti-Blemish Cream

  • Anti-mark action, 24h moisturising*, very good tolerance
  • Tested in combination with leading topical anti-acne treatments.
  • prod1
  • Anti-imperfections
    • Anti-Blemish Cream
    • Anti-Blemish Cream
    • Anti-Blemish Cream

      KERACNYL PP+

      Anti-Blemish Cream

      Helps to get rid of imperfections - Avoids skin marks - Compensates for the effects of drying treatments

      Helps to reduce inflamed pimples on acne-prone skin.

      • Anti-mark action, 24h moisturising*, very good tolerance
      • Tested in combination with leading topical anti-acne treatments.

      Usable by Teenagers - Adults

      Suitable Face

      Skin type Acne-prone skin

      Need Anti-imperfections

      Made in France

      KERACNYL PP+ anti-blemish cream helps to reduce inflamed pimples.
      Its anti-blemish effectiveness is demonstrated after 7 days**.
      Prescribed by dermatologists, it compensates for dryness and flaking caused by medical treatments*** and soothes immediately.
      24-hour hydration*.
      This non-greasy, non-sticky skin care product, suitable for adults and teenagers from the age of 12, also limits the appearance of marks.

      Benefit

      Promotes the disappearance of pimples after 7 days¹ and limits the appearance of marks. Soothes from the first application²

      Benefits

      • Acts on red pimples : the natural extract of MYRTACINE® helps to rebalance bacterial flora, CELASTROL® and VITAMIN PP help to reduce redness.
      • This treatment limits the appearance of marks and Soothes from the first application.
      • It helps to reduce feelings of discomfort caused by anti-acne medication.

      Product scent

      Fragrance-free

      Packaging that does not contain recycled material
      Fully recyclable packaging**

      *IH kinetics, single application on 22 subjects
      **Clinical study conducted on 40 subjects. Twice-daily application for 8 weeks.
      ***Tolerance study in combination with topical treatments carried out on 39 subjects, aged between 12 and 40 years old. Study period (D1-D29) : 2 applications per day (morning and evening).

      *IH kinetics, single application on 22 subjects.

      Application

      Frequency of use

      1 to 2 times a day

      Once or twice a day after cleansing with KERACNYL Foaming Gel
      Can be used alone or in combination with local drug treatment
      NON-COMEDOGENIC
      Designed to minimise the risk of allergic reactions

      Precaution to use :
      Avoid contact with eyes

      Ingredients

      WATER (AQUA). CAPRYLIC/CAPRIC TRIGLYCERIDE. CETEARYL ALCOHOL. ISOHEXADECANE. NIACINAMIDE. PENTYLENE GLYCOL. BUTYLENE GLYCOL. GLYCERIN. OCTYLDODECANOL. ORYZA SATIVA (RICE) STARCH (ORYZA SATIVA STARCH). POLYMETHYL METHACRYLATE. BENZOIC ACID. BUTYROSPERMUM PARKII (SHEA) BUTTER (BUTYROSPERMUM PARKII BUTTER). CETEARYL GLUCOSIDE. DICAPRYLYL CARBONATE. DISODIUM PHOSPHATE. GLYCERYL LAURATE. MYRTUS COMMUNIS LEAF EXTRACT. POLYACRYLATE-13. POLYISOBUTENE. POLYSORBATE 20. POTASSIUM PHOSPHATE. SODIUM CETEARYL SULFATE. SODIUM HYDROXIDE. SORBITAN ISOSTEARATE. STEARYL GLYCYRRHETINATE. TOCOPHEROL. TRIPTERYGIUM WILFORDII CALLUS EXTRACT. XANTHAN GUM

      82% natural ingredients

      The consumer is advised to systematically check the composition of the product before purchasing it.

      Myrtacine®

      Myrtacine®

      Active ingredient that helps fight the C. acnes bacteria by limiting its biofilm structure. Myrtacine soothes and corrects pimples
      Celastrol

      Celastrol

      1st innovative active ingredient from Pierre Fabre biotechnology, Celastrol, is of 100% natural origin and produced through the cultivation of plant cells. This soothing active ingredient directly targets keratinocytes to reduce the appearance of plaques and improve skin appearance

      Results

      • Effective after 7 days¹
      • Skin is immediately soothed² : 96%
      • Anti-mark actions¹

        ¹Clinical study conducted on 40 subjects. Twice-daily application for 8 weeks.
        ²Tolerance study in combination with topical treatments carried out on 39 subjects, aged between 12 and 40 years old. Study period (D1-D29) : 2 applications per day (morning and evening).

        We recommend

          Loading...